See more : Atlantic Avenue Acquisition Corp (ASAQ) Income Statement Analysis – Financial Results
Complete financial analysis of Rainbow Children’s Medicare Limited (RAINBOW.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rainbow Children’s Medicare Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Türk Telekomünikasyon Anonim Sirketi (TRKNF) Income Statement Analysis – Financial Results
- Passus S.A. (PAS.WA) Income Statement Analysis – Financial Results
- XBiotech Inc. (XBIT) Income Statement Analysis – Financial Results
- Hillcrest Energy Technologies Ltd. (HLRTF) Income Statement Analysis – Financial Results
- OEX S.A. (OEX.WA) Income Statement Analysis – Financial Results
Rainbow Children's Medicare Limited (RAINBOW.BO)
About Rainbow Children's Medicare Limited
Rainbow Children's Medicare Limited operates a multi-specialty paediatric and obstetrics, and gynaecology hospital chain in India. The company's children's health services include general paediatrics, intensive care unit, neonatology, surgery, gastroenterology and liver diseases, haematology and oncology, psychology, pulmonology, bone marrow transplant unit, dentistry, endocrinology, nephrology, nutrition, psychiatry, ENT, anaesthesia and pain management, cardiology, radiology, physiotherapy and rehabilitation, orthopaedics, ophthalmology, dermatology, allergy, rheumatology, and plastic surgery; and laboratory, speech and language therapy, occupational therapy, paediatric and metabolic medicine, developmental and behavioural, urology, neurosurgery, infectious disease, and cranio-maxillofacial surgery; intensive care unit, kidney transplant, and cochlear implant services; and genetics and metabolic medicines paediatrics, and cerebral palsy care services. Its women's health services comprise obstetrics and gynaecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after caesarean, breast feeding support, well women checkup, urogynaecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company's fertility care services include in vitro fertilization, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 12.86B | 11.74B | 9.74B | 6.40B | 7.07B | 5.33B |
| Cost of Revenue | 8.50B | 1.58B | 1.95B | 1.03B | 1.05B | 802.13M |
| Gross Profit | 4.36B | 10.15B | 7.79B | 5.37B | 6.02B | 4.52B |
| Gross Profit Ratio | 33.89% | 86.51% | 80.00% | 83.86% | 85.11% | 84.94% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 147.93M | 133.42M | 2.14B | 1.65B | 1.74B | 1.32B |
| Selling & Marketing | 290.24M | 272.90M | 215.10M | 90.49M | 140.63M | 113.54M |
| SG&A | 438.17M | 1.08B | 780.50M | 1.75B | 1.88B | 1.43B |
| Other Expenses | 370.64M | 308.65M | 189.37M | 4.77M | -91.22M | -53.61M |
| Operating Expenses | 11.20B | 7.09B | 5.57B | 4.45B | 4.70B | 3.61B |
| Cost & Expenses | 9.70B | 8.67B | 7.52B | 5.48B | 5.76B | 4.41B |
| Interest Income | 204.43M | 298.57M | 114.67M | 90.41M | 98.76M | 68.61M |
| Interest Expense | 625.30M | 551.95M | 532.03M | 432.44M | 446.06M | 387.99M |
| Depreciation & Amortization | 1.12B | 902.68M | 832.63M | 733.38M | 694.11M | 603.16M |
| EBITDA | 4.66B | 4.30B | 3.27B | 1.75B | 2.11B | 1.60B |
| EBITDA Ratio | 36.24% | 36.41% | 33.25% | 26.90% | 29.35% | 29.19% |
| Operating Income | 3.27B | 3.15B | 2.26B | 943.79M | 1.32B | 915.16M |
| Operating Income Ratio | 25.41% | 26.83% | 23.25% | 14.75% | 18.66% | 17.18% |
| Total Other Income/Expenses | -319.22M | -331.16M | -390.20M | -386.83M | -381.81M | -337.74M |
| Income Before Tax | 2.95B | 2.82B | 1.87B | 556.96M | 933.56M | 575.26M |
| Income Before Tax Ratio | 22.93% | 24.01% | 19.24% | 8.70% | 13.20% | 10.80% |
| Income Tax Expense | 765.26M | 694.02M | 486.73M | 161.28M | 380.16M | 129.36M |
| Net Income | 2.17B | 2.11B | 1.38B | 400.18M | 553.40M | 445.90M |
| Net Income Ratio | 16.88% | 17.97% | 14.20% | 6.25% | 7.83% | 8.37% |
| EPS | 21.38 | 20.89 | 14.75 | 4.36 | 6.07 | 4.39 |
| EPS Diluted | 21.38 | 20.89 | 14.40 | 4.25 | 5.92 | 4.39 |
| Weighted Avg Shares Out | 101.50M | 100.95M | 93.42M | 91.84M | 91.84M | 101.51M |
| Weighted Avg Shares Out (Dil) | 101.50M | 100.95M | 95.70M | 94.13M | 94.13M | 101.51M |
Source: https://incomestatements.info
Category: Stock Reports